Skip to main content
Home
Issues
2024
November 2024 Vol 17, Payers' Guide to FDA Updates
2023
December 2023 Vol 16, Payers' Guide to FDA Updates
September 2023 Vol 16, Payers' Guide to FDA Updates
June 2023 - Vol 16 No 1
Issue Archive
Topics
Conference Correspondent
ESMO 2024 - Small Cell Lung Cancer
EHA 2024 – Wrap-Up: Myelodysplastic Syndrome
ASCO 2024 – Wrap-Up: Myelodysplastic Syndrome
Multimedia
Videos
Interview with the Innovators
Editorial Board
About
About AHDB
Contact Us
Permissions
Editorial Policies
Editorial Process
Advertising Policy
Subscribe
Home
Issues
2024
November 2024 Vol 17, Payers' Guide to FDA Updates
2023
December 2023 Vol 16, Payers' Guide to FDA Updates
September 2023 Vol 16, Payers' Guide to FDA Updates
June 2023 - Vol 16 No 1
Issue Archive
Topics
Conference Correspondent
ESMO 2024 - Small Cell Lung Cancer
EHA 2024 – Wrap-Up: Myelodysplastic Syndrome
ASCO 2024 – Wrap-Up: Myelodysplastic Syndrome
Multimedia
Videos
Interview with the Innovators
Editorial Board
About
About AHDB
Contact Us
Permissions
Editorial Policies
Editorial Process
Advertising Policy
Laura Morgan
Authored Items
Challenges and Opportunities in Managing Type 2 Diabetes
Laura Morgan
June 2017 Vol 10, No 4
in
Conference Highlights AMCP
Defitelio (Defibrotide Sodium): First Drug Approved for Patients with Hepatic Veno-Occlusive Disease
Laura Morgan
March 2017, Vol 10, Eighth Annual Payers' Guide
in
Payers' Guide
,
FDA Approvals
US Healthcare Annual Spending Estimated to Rise by 5.8% on Average Through 2024
Laura Morgan
July/August 2015 Vol 8 No 5
in
Practice Management
Adherence to Ibrutinib Therapy Improves Outcomes in Patients with CLL
Laura Morgan
August 2015 Vol 8, Special Issue: Payers' Perspectives in Oncology
in
Leukemia
,
Oncology
The Impact of Rosacea and Acne on a Patient’s Quality of Life Is Comparable to Other Chronic Conditions
Laura Morgan
Payer Perspectives in Dermatology
in
Dermatology
,
Rosacea
Last modified: January 9, 2015
